Independently scored across 5 dimensions · Updated weekly · No paid placements
Hims & Hers logo

Hims & Hers

Fastest onboarding in the chart, broadest brand recognition, and a compounded program now closed to new patients
Visit Hims & Hers ↗
7.4
Out of 10
Starts From
$199/mo
includes medication
Lock-In
Month-to-month
Time to Rx
1 day
Asynchronous
Score
7.4 / 10
Rank #3 of 20

Verdict

Same-day prescription, no lock-in, and brand-name confidence. The famous $199 compounded era ended in March 2026 after the Novo Nordisk settlement; new patients now route to branded products only.

Best for

  • Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable all-in monthly pricing.

Not for

  • Patients who specifically wanted Hims's old $199 compounded semaglutide tier — that path is closed to new patients as of March 2026.

Pricing

Oral Wegovy $249/mo, injectable Wegovy $299/mo, Zepbound $399/mo. Compounded semaglutide grandfathered for legacy patients only.

Cash-pay all-in starts at $199/moThis price includes medication.

Lock-in & cancellation

Month-to-month

Online self-serve cancellation. The most-cited complaint in member feedback is surprise renewal billing — auto-renewal is on by default and the cancellation flow has been called friction-heavy.

Medication options

Now FDA-approved branded primarily, via Novo Nordisk partnership announced April 2026. 503A-compounded grandfathered for existing patients only.

FDA-approved branded

503A-compounded

Other medications

Regulatory notes
  • Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
  • Now distributing branded Wegovy under official Novo partnership

Onboarding experience

Time to first prescription: 1 day.
Consultation type: Asynchronous (no video required).
Requirements: Self-reported weight, BMI, medical history. No labs at sign-up..

Member feedback

Trustpilot 3.0 across 8,000+ reviews. Reddit sentiment in r/glp1 and r/wegovy_weightloss is mixed: appetite suppression praised, billing and cancellation friction is the dominant negative.

What works

  • Fastest onboarding of any major program (often same-day)
  • Brand recognition and trust signal
  • Clean app and notification flow

What to watch

  • Surprise renewal billing
  • Compounded program pulled mid-subscription for some patients
  • Cancellation flow described as friction-heavy
  • Customer support response times

How we scored Hims & Hers

Five dimensions, ten points each, weighted equally. Overall is the simple average.

7
Pricing
Transparency
9
Cancellation
Terms
9
Onboarding
Experience
7
Medication
Options
5
Member
Outcomes

Read the full methodology →

Frequently asked questions

Can I still get the $199 compounded semaglutide from Hims?
Only if you were already on the Hims compounded program before March 9, 2026. New patient enrollment in compounded semaglutide ended that date as part of the Novo Nordisk settlement. New patients now choose between branded Wegovy ($249-$299/mo all-in) or Zepbound ($399/mo all-in).
Why are there so many billing complaints about Hims?
Two structural reasons. First, auto-renewal is on by default, and the cancellation flow takes more clicks than typical e-commerce. Second, the compounded-to-branded transition in 2026 forced unexpected price changes for some legacy patients. The product itself is not low-quality; the billing UX is the friction point.
How fast can I actually get a Hims prescription?
Most async onboardings result in a prescription within 24 hours of completing the intake form. If your intake flags a contraindication or insurance question, the timeline extends to 2-3 days. This is among the fastest in the category.

Alternatives to Hims & Hers

If Hims & Hers isn't the right fit, here are three programs we'd consider as next options:

See the full chart →

Why you can trust GLP Chart Same scoring framework applied to every program. No paid placements. No removal of unfavorable information at advertiser request. Pricing is pulled from each provider's public-facing page weekly.
Independent comparison site. Not a medical provider, telehealth platform, or pharmacy. Information is educational, not medical advice. Always consult a licensed clinician. We may earn a commission on partner links at no cost to you.